Safety Surveillance During the Introduction of Novel Oral Poliovirus Vaccine Type 2 (nOPV2) in the Central African Republic: Findings from Passive AEFI and Active AESI Surveillance
0Citations signalées
3Institutions associées
3Pays d’affiliation
Résumé indisponible dans les métadonnées reçues.
Institutions
Sujets associés
Viral Infections and Immunology ResearchRespiratory viral infections researchSARS-CoV-2 and COVID-19 Research